FarmavitaR+ Journal
Business News
Dendrimers - Drug Delivery to Cancer | Dendrimers - Drug Delivery to Cancer |
|
|
| Written by Dr.(Mrs)Swarnlata Saraf | |||||||||||||||||
| Sunday, 16 December 2007 | |||||||||||||||||
Page 3 of 3 Conclusion
The future of dendrimer drug delivery lies is fine tuning the carrier to incorporate variety of drugs and complex protein to ensure the vectorization of dendrimer-complex\conjugates to desired cells\tissues. The major focus will be on development of dendrimer based on new concept of biommetism\biomorphism with plasma stability and capability to target cell in various body compartments. Novel supramolecular structures based on polyethylene oxide copolymers and dendrimers are being intensively researched for delivery of genes and macromolecules. Hydrogels that can respond to a variety of physical, chemical and biological stimuli hold enormous potential for design of closed-loop drug-delivery systems. Design and synthesis of novel combinations of polymers will expand the scope of new drug-delivery systems in the future. References 1. Dendrimer in gene delivery Advanced drug delivery review, vol. 57 Dec 2005 page 2177–2202. 2. Immunological application of DNA Dendrimer, Clinical immunology vol. 119 supplements page196. 3. Dendrimer biomedical application –reflection on the field. Advanced drug delivery review, vol. 57 Dec 2005 page 2106–2129. 4. Dendrimers Biocompatibility and toxicity Advanced drug delivery review, vol. 57 Dec 2005 page 2177–2202. 5. Dendrimer and dendritic polymer in drug delivery drug discovery today, vol 10, Jan. 2005, page 35-43. 6. Virus based nanoparticals platform technologies for diagnostic imaging, advanced drug delivery reviews vol. 58 Dec 2006 page 1505- 1572. 7. A to Z Nanotechnology dendrimer definition, dendrimer in medicine, other industry application and examples of product. 8. Synthesis, characterization and stability of dendrimer prodrug, international journal of pharmaceutics, vol. 308,Feb 2006, page 175 –182. 9. In vitro biological evaluation of high molecular weight hyper branched polyglycerol.biomaterials, vol. 28 issue 32 Nov 2007 page no 4797-4787. 10.Biological properties of low molecular mass peptide dendrimer, international journal of pharmaceutics, vol. 309, Feb 2006, page 208-217 .
Only registered users can write comments! Powered by !JoomlaComment 3.12 Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved.Newer news items
Related Items
|
|||||||||||||||||
| Last Updated ( Tuesday, 29 January 2008 ) | |||||||||||||||||
| < Prev | Next > |
|---|
FarmavitaR+ Registration is FreeRegister yourself to FarmavitaR+ and post your PR, professional articles, comments about articles. Participate in discussions at message board and network with other pharmaceutical professionals. Click here for registration! |